High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant NPM1 and FLT3 Mutations

Compared to solid tumors, the role of PD-L1 in hematological malignancies is less explored, and the knowledge in this area is mostly limited to lymphomas. However, several studies indicated that PD-L1 is also overexpressed in myeloid malignancies. Successful treatment of the acute myeloid leukemia (...

Descripción completa

Detalles Bibliográficos
Autores principales: Brodská, Barbora, Otevřelová, Petra, Šálek, Cyril, Fuchs, Ota, Gašová, Zdenka, Kuželová, Kateřina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600137/
https://www.ncbi.nlm.nih.gov/pubmed/31185600
http://dx.doi.org/10.3390/ijms20112823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600137/
https://www.ncbi.nlm.nih.gov/pubmed/31185600
http://dx.doi.org/10.3390/ijms20112823

Ejemplares similares